 |
|
Efficacy of peginterferon and ribavirin is associated with the IL28B gene in Korean patients with chronic hepatitis C
Seok Hoo Jeong, Young Kul Jung, Jae Won Yang, Sang Jin Park, Jong Woo Kim, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
Clin Mol Hepatol. 2012;18(4):360-367. Published online 2012 Dec 21 DOI: https://doi.org/10.3350/cmh.2012.18.4.360
|
|
Citations to this article as recorded by
 Uncovering the immune microenvironment and molecular subtypes of hepatitis B-related liver cirrhosis and developing stable a diagnostic differential model by machine learning and artificial neural networks
Shengke Zhang, Chenglu Jiang, Lai Jiang, Haiqing Chen, Jinbang Huang, Jieying Zhang, Rui Wang, Hao Chi, Guanhu Yang, Gang Tian
Frontiers in Molecular Biosciences.2023;[Epub] CrossRef Genetic screening to avoid adverse drug reactions from medication use and approach patients' better outcomes: A lesson learn from the report of the Queen Savang Vadhana Memorial Hospital
Kessada Tunwongsa, Malinee Chonnawakul, Nopavut Geratikornsupuk, Karunrat Tewthanom
Health Science Reports.2022;[Epub] CrossRef The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015
Eun Sun Jang, Moran Ki, Hwa Young Choi, Kyung-Ah Kim, Sook-Hyang Jeong
Hepatology International.2019; 13(5): 599. CrossRef Final Report of Unmet Needs of Interferon-Based Therapy for Chronic Hepatitis C in Korea: Basis for Moving into the Direct-Acting Antiviral Era
Eun Sun Jang, Young Seok Kim, Kyung-Ah Kim, Youn Jae Lee, Woo Jin Chung, In Hee Kim, Byung Seok Lee, Sook-Hyang Jeong
Gut and Liver.2017; 11(4): 543. CrossRef Real-life prevalence of resistance-associated variants against non-structural protein 5A inhibitors and efficiency of Daclatasvir + Asunaprevir therapy in Korean patients with genotype 1b hepatitis C
Jung Hwan Yu, Jung Il Lee, Kwan Sik Lee, Ja Kyung Kim
Virology Journal.2017;[Epub] CrossRef KASL clinical practice guidelines: management of hepatitis C
Clinical and Molecular Hepatology.2016; 22(1): 76. CrossRef Incidence and risk factors of hepatitis C virus infection among human immunodeficiency virus (HIV) patients in a large HIV clinic in South Korea
Shinwon Lee, Sun Hee Lee, Su Jin Lee, Kye-Hyung Kim, Jeong Eun Lee, Heerim Cho, Seung Geun Lee, Joo Seop Chung, Ihm Soo Kwak
The Korean Journal of Internal Medicine.2016; 31(4): 772. CrossRef Lower Incidence of Hepatocellular Carcinoma and Cirrhosis in Hepatitis C Patients with Sustained Virological Response by Pegylated Interferon and Ribavirin
Chansoo Moon, Kyu Sik Jung, Do Young Kim, Oidov Baatarkhuu, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Sang Hoon Ahn, Kwang-Hyub Han
Digestive Diseases and Sciences.2015; 60(2): 573. CrossRef IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors
Daniele Blasquez Olmedo, Samária Ali Cader, Luís Cristóvão Porto
Journal of Medical Virology.2015; 87(10): 1702. CrossRef No association between the IL28B SNP and response to peginterferon plus ribavirin combination treatment in Korean chronic hepatitis C patients
Nae-Yun Heo, Young-Suk Lim, Woochang Lee, Minkyung Oh, Jiyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee, Dong Jin Suh
Clinical and Molecular Hepatology.2014; 20(2): 177. CrossRef KASL clinical practice guidelines: Management of Hepatitis C
Clinical and Molecular Hepatology.2014; 20(2): 89. CrossRef Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
Young Kul Jung, Ju Hyun Kim
Clinical and Molecular Hepatology.2013; 19(1): 26. CrossRef The Impact of Inosine Triphosphatase Variants on Hemoglobin Level and Sustained Virologic Response of Chronic Hepatitis C in Korean
Ju Seung Kim, Sung-Min Ahn, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
Journal of Korean Medical Science.2013; 28(8): 1213. CrossRef
|